Recombinant vaccine confers more protection against influenza
A high-dose recombinant influenza vaccine is more effective than standard-dose vaccine among adults aged 50 to 64 years, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.
Dec 14, 2023
0
4